- Report
- November 2026
- 414 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 84 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- May 2026
- 180 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- January 2026
- 185 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- January 2026
- 185 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- January 2026
- 180 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- January 2026
- 181 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- January 2026
- 180 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- January 2026
- 185 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- January 2026
- 185 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- January 2026
- 185 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- January 2026
- 185 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- January 2026
- 185 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- November 2025
- 185 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- November 2025
- 185 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- November 2025
- 180 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- May 2026
- 180 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- February 2026
- 250 Pages
Global
From €4153EUR$4,490USD£3,466GBP
- Report
- January 2026
- 250 Pages
Global
From €4153EUR$4,490USD£3,466GBP
- Report
- December 2026
- 250 Pages
Global
From €4153EUR$4,490USD£3,466GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more